M E Guseva

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Monoclonal Antibody

Multiple Sclerosis

Patient Reported Outcomes

Top Venues

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

This page only lists publications with an associated author ORCID identifier.

Publications

Alexey Boyko, N Yu Lasch, M E Guseva
[Optimal patient profile for ofatumumab treatment: analysis of Russian data from the Phase 3 study]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (7. Vyp. 2) (2024)
Stella Sivertseva, K S Anfilofeva, A V Zotova, V A Kazantsev, A Yu Belkina, L I Volkova, M E Guseva, Alexey Boyko
[The effectiveness of tele-rehabilitation for patients with multiple sclerosis during the COVID-19 pandemic in 2020-2021 was evaluated in this study]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (3) (2024)
Alexey Boyko, N Yu Lasch, M E Guseva
[Optimal patient profile for ofatumumab treatment: analysis of Russian data from the Phase 3 study]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (7. Vyp. 2) (2024)
Stella Sivertseva, K S Anfilofeva, A V Zotova, M A Sherman, M E Guseva, Alexey Boyko
[Dance therapy in the rehabilitation of neurological diseases]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (7. Vyp. 2) (2022)
Alexey Boyko, N F Smirnova, I A Shchukin, M E Guseva, E V Popova
[Ofatumumab - a new drug for the treatment of multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (7. Vyp. 2) (2021)
Stella Sivertseva, A A Belkin, L B Artem'eva, M E Guseva
[The use of music therapy in the treatment of adverse effects in patients with multiple sclerosis treated with alemtuzumab]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 120 (7. Vyp. 2) (2020)